IISc Bengaluru-backed AI and Robotics and Technology Park is seeking approval from the Indian regulator to raise a $100m venture fund.

Intel Capital was among the investors bringing the fabless semiconductor producer’s total funding to over $350m and its valuation above $2.5bn.

With a remit across healthcare, life sciences and advanced materials, Merck’s corporate venturing unit is scoping an opportunity-filled landscape.

Radiopharmaceuticals developer Precirix completed an $88m series B round featuring Novo while corporate-backed kitchen technology provider Bear Robotics raised $81m.

Q&A with Victoria Lietha, principal, ABB Technology Ventures

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Legend Capital was among the investors in the synthetic biology-derived materials producer’s fourth round, which helped lift its total funding to over $100m.

SAIC Motor’s Hengxu Capital helped allosteric drug developer Nutshell Therapeutics close a $40m round while cancer therapy developer Impact Therapeutics secured series D1 funding.

Lunar expanded its series D round to $307m while RefleXion Medical raised $80m and Silent Eight raked in $40m.

SATT Aquitaine has signed up INRAE and its tech transfer arm for a five-year agreement to help commercialise its research.